Treatment of Peritoneal Dissemination in Stomach Cancer Patients With Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Rationale and Design of the PERISCOPE Study

Rosa T van der Kaaij   ^{1 *} , MD ;   Hidde JW Braam   ^{2 *} , MD, PhD ;   Henk Boot   ³ , MD, PhD ;   Maartje Los   ⁴ , MD, PhD ;   Annemieke Cats   ³ , MD, PhD ;   Cecile Grootscholten   ⁵ , MD, PhD ;   Jan HM Schellens   ⁶ , MD, PhD ;   Arend GJ Aalbers   ¹ , MD ;   Alwin DR Huitema   ^{7, 8} , PhD ;   Catherijne AJ Knibbe   ⁹ , PhD ;   Djamila Boerma   ² , MD, PhD ;   Marinus J Wiezer   ² , MD, PhD ;   Bert van Ramshorst   ² , MD, PhD ;   Johanna W van Sandick   ¹ , MD, PhD

¹ The Netherlands Cancer Institute – Antoni van Leeuwenhoek Hospital, Department of Surgical Oncology, Amsterdam, The Netherlands

² St. Antonius Hospital, Department of Surgery, Nieuwegein, The Netherlands

³ The Netherlands Cancer Institute – Antoni van Leeuwenhoek Hospital, Department of Gastroenterology, Amsterdam, The Netherlands

⁴ St. Antonius Hospital, Department of Medical Oncology, Nieuwegein, The Netherlands

⁵ The Netherlands Cancer Institute – Antoni van Leeuwenhoek Hospital, Department of Medical Oncology, Amsterdam, The Netherlands

⁶ The Netherlands Cancer Institute – Antoni van Leeuwenhoek Hospital, Department of Clinical Pharmacology, Amsterdam, The Netherlands

⁷ The Netherlands Cancer Institute – Antoni van Leeuwenhoek Hospital, Department of Pharmacy and Pharmacology, Amsterdam, The Netherlands

⁸ University Medical Center Utrecht, Department of Clinical Pharmacy, Utrecht, The Netherlands

⁹ St. Antonius Hospital, Department of Pharmacology, Nieuwegein, The Netherlands

*these authors contributed equally